Comparing Moderately and Ultra Hypofractionated Radiation Treatments for Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a multi-institution, randomized, non-inferiority Phase II trial comparing external beam radiotherapy delivered as 54 Gy in 20 fractions to prostate bed +/- 44 Gy in 20 fractions to pelvic lymph nodes delivered daily with external beam radiotherapy delivered as 30 Gy in 5 fractions to prostate bed +/- 25 Gy in 5 fractions to pelvic lymph nodes delivered on alternate days.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony rozpoznaniem rak prostaty
- •Operacja usunięcia prostaty wykonana co najmniej 6 miesięcy wcześniej
- •Dobry stan ogólny (ECOG 0-1)
- •Kwalifikacja do radioterapii po operacji
✗ Disqualifies
- •Wcześniejsza radioterapia w okolicy miednicy
- •Przeszkody medyczne do radioterapii
- •Potwierdzony nowotwór w innych częściach ciała
- •Widoczne ogniska nowotworu w loży prostaty lub węzłach chłonnych na obrazach
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 8, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (3)
London Health Sciences Centre
London, Canada
Sunnybrook Health Sciences Centre - Sunnybrook Research Institute
Toronto, Canada
University Health Network - Princess Margaret Cancer Centre
Toronto, Canada
Trial contact
Andrew McPartlin, MBChB
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/6/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.